Effects of the 5-HT6 receptor antagonist, SB-271046, in animal models for schizophrenia

Pharmacology Biochemistry and Behavior

Volumn 71, Issue 4, 2002, Pages 635-643

  Pouzet, B ^a   Didriksen, M ^a   Arnt, J ^a  

^a H LUNDBECK A S   (Denmark)

Author keywords

5 HT6; Activity; Catalepsy; Prepulse inhibition; SB 271046; Schizophrenia; Social interaction

Indexed keywords

5 CHLORO N (4 METHOXY 3 PIPERAZIN 1 YL PHENYL) 3 METHYL 2 BENZOTHIOPHENESULFONAMIDE; 5 CHLORO N [4 METHOXY 3 (1 PIPERAZINYL)PHENYL] 3 METHYL 2 BENZOTHIOPHENESULFONAMIDE; CLOZAPINE; DEXAMPHETAMINE; OLANZAPINE; PHENCYCLIDINE; SEROTONIN 6 RECEPTOR; SEROTONIN ANTAGONIST; SERTINDOLE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CATALEPSY; CONTROLLED STUDY; DOSE RESPONSE; DRUG ANTAGONISM; DRUG EFFECT; DRUG EFFICACY; DRUG POTENCY; DRUG SPECIFICITY; HYPERACTIVITY; MALE; MONOTHERAPY; NONHUMAN; PREPULSE INHIBITION; PRIORITY JOURNAL; RAT; SCHIZOPHRENIA; SOCIAL INTERACTION;

ANIMALS; CATALEPSY; CENTRAL NERVOUS SYSTEM STIMULANTS; CLOZAPINE; DEXTROAMPHETAMINE; DOSE-RESPONSE RELATIONSHIP, DRUG; HYPERKINESIS; MALE; RATS; RATS, WISTAR; RECEPTORS, SEROTONIN; SCHIZOPHRENIA; SEROTONIN ANTAGONISTS; SOCIAL BEHAVIOR; STARTLE REACTION; SULFONAMIDES; THIOPHENES;

ANIMALIA;

EID: 0036119234     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0091-3057(01)00743-2     Document Type: Article

References (44)

1. Pharmacological specificity of conditioned avoidance response inhibition in rats: Inhibition by neuroleptics and correlation to dopamine receptor blockade
2. Differential effects of classical and newer antipsychotics on the hypermotility induced by two dose levels of D-amphetamine
3. Screening models for antipsychotic drugs
4. Do novel antipsychotics have similar pharmacological characteristics? A review of the evidence
5. Antagonism of phencyclidine-induced deficits in prepulse inhibition by the putative atypical antipsychotic olanzapine
6. Clozapine antagonizes phencyclidine-induced deficits in sensorimotor gating of the startle response
7. 6 antisense oligonucleotide i.c.v. affects rat performance in the water maze and feeding
8. 6 receptor antagonist, Ro 04-6790, in rats
9. 6 receptor in the rat brain: A study using antisense oligonucleotides
10. 6 receptors in nigro-striatal functions in rodents
11. 6 receptors as emerging targets for drug discovery
12. 6 receptor antagonist
13. Antipsychotic agents antagonize non-competitive N-methyl-D-aspartate antagonist-induced behaviors
14. 6 antagonist SB-271046 on striatal and frontal cortex extracellular concentrations of noradrenaline, dopamine, 5-HT, glutamate, and aspartate
15. Oxytocin modulates psychomimetic-induced deficits in sensorimotor gating
16. Antipsychotic potential of CCK-based treatments: An assessment using the prepulse inhibition model of psychosis
17. Novel antipsychotic-like effects on prepulse inhibition of startle produced by a neurotensin agonist
18. 6 receptor mRNA levels in rat brain
19. 6 receptor-like material in the rat central nervous system
20. Pharmacological studies of prepulse inhibition models of sensorimotor gating deficits in schizophrenia: A decade in review
21. Blockade of phencyclidine-induced hyperlocomotion by olanzapine, clozapine, and serotonin receptor subtype selective antagonists in mice
22. 6 receptors
23. 6 receptor antagonist SB-271046
24. The atypical antipsychotic, remoxipride, blocks phencyclidine-induced disruption of prepulse inhibition in the rat
25. Effects of phencyclidine and phencyclidine biologs on sensorimotor gating in the rat
26. Characterization of endogenous serotonin-mediated regulation of dopamine release in the rat prefrontal cortex
27. Cloning and expression of a novel serotonin receptor with high affinity for tricyclic psychotropic drugs
28. 6 receptors in rat nucleus accumbens by antisense oligonucleotides
29. Effects of acute versus chronic treatment with typical or atypical antipsychotics on D-amphetamine-induced sensorimotor gating deficits in rats
30. 7 receptor antagonist SB-258741 in animal models of schizophrenia
31. 6 antagonist SB-271046
32. Binding of typical and atypical antipsychotic agents to 5-hydroxytryptamine-6 and 5-hydroxytryptamine-7 receptors
33. 6 receptor antagonist
34. Automation of the social interaction test by a video-tracking system: Behavioural effects of repeated phencyclidine treatment
35. Phencyclidine-induced stereotyped behaviour and social isolation in rats: A possible animal model of schizophrenia
36. Effect of novel antipsychotic drugs on phencyclidine-induced strereotyped behaviour and social isolation in the rat social interaction test
37. A test of the predictive validity of animal models of schizophrenia based on phencyclidine and D-apomorphine
38. 6 receptors
39. Clozapine and haloperidol in an animal model of sensorimotor gating deficits in schizophrenia
40. Assessing the validity of an animal model of deficient sensorimotor gating in schizophrenic patients
41. Seroquel restores sensorimotor gating in phencyclidine-treated rats
42. Involvement of serotonin 2A receptors in phencyclidine-induced disruption of prepulse inhibition of the acoustic startle in rats
43. 6 receptor subtype in the rat brain
44. 7 receptors in HeLa cells